Billerud AB (publ) (STO:BILL)

Intra-Cellular Therapies Revenue

Billerud AB had revenue of 10.24B SEK in the quarter ending June 30, 2025, a decrease of -4.83%. This brings the company's revenue in the last twelve months to 43.73B, up 6.40% year-over-year. In the year 2024, Billerud AB had annual revenue of 43.57B with 5.35% growth.

• Revenue (ttm): 43.73B
• Revenue Growth: +6.40%
• P/S Ratio: 0.50
• Revenue / Employee: 7.36M
• Employees: 5,822
• Market Cap: 21.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.57B	2.21B	5.35%
Dec 31, 2023	41.36B	-1.36B	-3.18%
Dec 31, 2022	42.72B	16.42B	62.45%
Dec 31, 2021	26.30B	2.35B	9.83%
Dec 31, 2020	23.94B	-582.00M	-2.37%